Pharmafile Logo
Pharmafocus logo
Advanced Search

talc powder

Showing 5 posts of 5 posts found.

johnsons_baby_powder_massage

Johnson & Johnson loses bid to overturn baby powder cancer case

June 24, 2020
Research and Development Johnson and Johnson, talc, talc powder

Johnson & Johnson have had a bid to overturn a verdict that blamed the company’s baby powder for giving women …

News
26795063175_fe37f336f7_b

Jury orders Johnson & Johnson to pay $750 million in latest baby powder case

February 7, 2020
Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder

Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …

News

Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial

January 28, 2020
Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder

Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …

News
26795071995_1a72be4ca3_b

No link between talc and ovarian cancer, new study reveals

January 8, 2020
Research and Development . Johnson & Johnson, Johnson & Johnson, baby powder, talc, talc powder

Researchers examining data from over 252,000 women have concluded that there is no statistically significant link between the use of …

News
johnson_and_johnson_jj

J&J ordered to pay $4.68 billion to talc-powder plaintiffs

July 13, 2018
Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder

A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …

News

Latest content

Austrian state secretary to speak at FlyPharma Europe 2023

September 29, 2023

Karuna Therapeutics submits NDA to FDA for schizophrenia treatment

September 29, 2023

Kura Oncology shares preclinical data for NSCLC treatment

September 29, 2023

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023

Avalyn Pharma raises $175m in Series C financing for inhalation therapies

September 28, 2023